EN
HI
Parmax Pharma Chart
Parmax Pharma Share Key Metrics
Volume
2345.00
Market Cap
12.68 CR
LTQ@LTP
95@34.00
ATP
33.94
Var Margin
100 %
Circuit Range
27.12-40.66
Delivery %
98.95 %
Value
79589.30
ASM/GSM
No
Market Lot
1
Summary
Parmax Pharma share price is ₹34 as of 21 May, 2026. The stock Parmax Pharma intraday movement has stayed between ₹32.01 and ₹34.15, while on a 52-week basis,Parmax Pharma price 52 week high is ₹47.84 & its 52 week low is ₹22.60.
In terms of trading activity, Parmax Pharma has recorded a volume of 2345 shares, The Parmax Pharma has a market cap of ₹3741300 CR. The stock’s Average Traded Price (ATP) stands at ₹33.94, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 95 @ ₹34.00.
Parmax Pharma operates within a circuit range of ₹27.12 – ₹40.66, with a Value of ₹79589.30. The Delivery Percentage for the day is 98.95%. Additionally, Parmax Pharma currently falls under the No framework, and trades with a market lot size of 1.
Parmax Pharma Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
71.81
Sector P/B
3.44
Sec. Div. Yield
0.55
Parmax Pharma Resistance and Support
Pivot 32.96
Resistance
First Resistance
34.92
Second Resistance
35.96
Third Resistance
37.92
Support
First Support
31.92
Second Support
29.96
Third Support
28.92
Parmax Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
Parmax Pharma News
Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Change in Management
Parmax Pharma's Board re-appointed Dr. Umang Gosalia as Managing Director for a period of five years, effective from June 28, 2026. This re-appointment is subject to approval from the shareholders at the upcoming Annual General Meeting or Extra-ordinary General Meeting.
May 02 2026 17:05:00
About Parmax Pharma
NSE : 0
BSE : 540359
ISIN : INE240T01014
Parmax Pharma Limited was incorporated as a public limitedcompany on 02-11-1994 and the company received theCertificate of commencement of business from the Registrarof Companies Gujarat on 10-3-95. The Company is planningto set up a bulk drug plant to manufacture Amoxycillin trihydrade ampicillin tri hydrade Cephalexin mono hydrateand Nalidixic acid at Hadamtala Gondal. Dist Rajkot.
Parmax Pharma Management
| Name | Position |
|---|---|
| Umang A Gosalia | Managing Director |
| Nikhil Uchat | Non Executive Independent Director |
Parmax Pharma Similar Stocks
Clinitech Laboratory Ltd.
40.40
1.90 (4.94%)
Starsource Multitrade Ltd.
120.00
5.00 (4.35%)
Norris Medicines Ltd.
13.00
0.24 (1.88%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Colinz Laboratories Ltd.
42.05
0.04 (0.10%)
Broach Lifecare Hospital Ltd.
17.88
0.00 (0.00%)
Unjha Formulations Ltd.
19.34
0.04 (0.21%)
Ortin Global Ltd.
13.75
0.00 (0.00%)
Parmax Pharma FAQs
The Buying Price of Parmax Pharma share is 34 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Parmax Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Parmax Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Parmax Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Parmax Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Parmax Pharma’s valuation compare Sector P/E, P/B which are 71.81 & 3.44 with sector averages, along with growth rates and financial metrics.
The Market Cap of Parmax Pharma is 12.68 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Parmax Pharma share price is 47.84 & 22.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Parmax Pharma belongs to the Healthcare sector.
